Related Experiment Video
Updated: Jun 20, 2026
Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools
Published on: August 19, 2025
Proteomic differential display analysis identified upregulated astrocytic phosphoprotein PEA-15 in human malignant
Yasuhiro Kuramitsu1, Hiromu Miyamoto, Toshiyuki Tanaka
1Department of Biochemistry and Functional Proteomics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, Japan. climates@yamaguchi-u.ac.jp
Abstract:
We performed proteomic differential display analysis of human malignant pleural mesothelioma (MPM) cell lines and a human pleural mesothelial cell line by using 2-DE and LC-MS/MS. The human MPM cell lines were NCI-H28, NCI-H2052 and NCI-H2452, and the human pleural mesothelial cell line was MeT-5A. Between MeT-5A and NCI-H2052, we found 38 protein spots whose expression levels were different, from the results of 2-DE; 28 protein spots appeared higher, and 10 other protein spots lower in NCI-H2052 than in MeT-5A. These spots were analyzed by LC-MS/MS analysis and identified by a peptide sequence tag. However, from the results of 2-DE of the other cell lines, there was only one consistently upregulated protein, astrocytic phosphoprotein PEA-15, in all three MPM cell lines. Western blotting using specific antibodies against PEA-15 confirmed the elevated expression level of PEA-15 in all three MPM cell lines compared with MeT-5A cells and normal pleura tissues from patients. PEA-15 was knocked down in NCI-H2052 cells, and the proliferation of PEA-15-silenced NCI-H2052 cells was suppressed 7-15% compared with negative control cells. These results suggest that PEA-15 expression is likely to be associated with the tumorigenesis of MPM.
Insights
Researchers identified astrocytic phosphoprotein PEA-15 as consistently upregulated in malignant pleural mesothelioma (MPM) cell lines. Silencing PEA-15 suppressed MPM cell proliferation, suggesting its association with cancer development.
Area of Science:
- Proteomics
- Cancer Biology
- Molecular Oncology
Background:
- Malignant pleural mesothelioma (MPM) is a rare but aggressive cancer.
- Identifying specific molecular markers is crucial for understanding MPM tumorigenesis and developing targeted therapies.
Purpose of the Study:
- To identify differentially expressed proteins in human MPM cell lines compared to normal mesothelial cells.
- To investigate the role of identified proteins in MPM cell proliferation.
Main Methods:
- Proteomic analysis using 2D-gel electrophoresis (2-DE) and liquid chromatography-tandem mass spectrometry (LC-MS/MS).
- Western blotting to confirm protein expression levels.
- Gene silencing (knockdown) experiments to assess functional impact on cell proliferation.
Main Results:
- Differential display identified 38 protein spots with altered expression between MPM and normal mesothelial cells.
- Astrocytic phosphoprotein PEA-15 was consistently upregulated in all three MPM cell lines studied.
- Knockdown of PEA-15 in NCI-H2052 cells resulted in a 7-15% suppression of cell proliferation.
Conclusions:
- PEA-15 is a potential biomarker for malignant pleural mesothelioma.
- Elevated PEA-15 expression is associated with increased proliferation in MPM cells.
- PEA-15 may play a role in the tumorigenesis of malignant pleural mesothelioma.
